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DAX-1 and SF-1 are members of the orphan nuclear
receptor superfamily that are critical regulatory
components of the hypothalamic-pituitary-adrenal-
gonadal axis. In adrenal and gonadal tissues they
regulate the expression of the cytochrome P450
steroid hydroxylase genes, key mediators of steroido-
genesis. The identi®cation of a number of steroid
hydroxylases in human skin prompted us to investi-
gate the presence of DAX-1 and SF-1. Immuno-
histochemical analysis of human skin revealed a
distinctive staining pattern for DAX-1 and SF-1 in
skin and its appendages. Prominent staining for
DAX-1 was con®ned to the epidermis, sebaceous
glands, sweat glands, and outer root sheath of the
hair follicle with weaker expression in the inner root
sheath, matrix cells, and dermal papilla cells.
Similarly, SF-1 was also detected in the epidermis
but displayed a scattered nuclear pattern across all
layers. SF-1 immunoreactivity was also detected in
the exocrine glands and was stronger than DAX-1 in
the inner root sheath, matrix cells, and dermal
papilla cells. Co-localization of DAX-1 and SF-1 was
demonstrated by immunocytochemistry in the
HaCaT keratinocyte cell line, primary keratinocytes,
preadipocytes, and dermal papilla cells. Reverse tran-
scriptase-polymerase chain reaction analysis demon-
strated the expression of DAX-1 and SF-1 mRNA in
whole human skin and Western analysis also con-
®rmed the presence of DAX-1 protein in skin-
derived cells. Our investigations demonstrate that
two important regulators of steroidogeneisis are pre-
sent in human skin and its appendages. These tran-
scription factors may have a role in cutaneous
steroidogenesis and thus be involved in hair follicle
cycling or pathologies associated with steroids.
Further studies are needed to determine the func-
tional roles of DAX-1 and SF-1 in human skin.
Keywords: adrenal/epidermis/hair/nuclear receptor/steroids.
Journal of Investigative Dermatology 117:1559±1565, 2001
T
he cytochrome P450 steroid hydroxylases are a group
of enzymes predominantly located in the adrenal
cortex and gonads, where they act in a sequential
cascade converting cholesterol, the common precursor
of steroid hormones, into biologically active steroids.
The steroid hormones synthesized by these enzymes are involved in
a plethora of physiologic and developmental processes, including
ion balance, metabolism, sexual development, and reproductive
function.
Studies of several mouse steroid hydroxylase promoters led to the
identi®cation and cloning of an orphan nuclear receptor,
steroidogenic factor 1 (SF-1) (Lala et al, 1992), also known as
adrenal 4 binding protein (Ad4BP) (Honda et al, 1993). It was found
to induce the expression of all the steroid hydroxylases by binding
as a monomer to consensus estrogen receptor half site (AGGTCA)
regulatory elements in their gene promoters. Disruption of Ftzf1,
the gene that encodes murine SF-1, causes adrenal gland and
gonadal de®ciency accompanied by prominent XY sex reversal
(Luo et al, 1994), which is consistent with the phenotype recently
detected in a female XY human who had a heterozygous mutation
in the FTZ-F1 gene (Achermann et al, 1999). These studies
demonstrated the critical role that SF-1 plays in the development
and function of these endocrine organs.
SF-1 has also been found to regulate the expression of other
components of the hypothalamic-pituitary-gonadal-adrenal axis
such as the adrenocorticotrophic hormone receptor (ACTH-R),
the gonadotrophin-releasing hormone receptor (GnRH-R), the
b-subunit of luteinizing hormone (LHb) and follicle stimulating
hormone b-subunit (FSHb), the cholesterol transporter steroido-
genic acute regulatory (StAR) protein, and MuÈllerian inhibiting
substance, a member of the transforming growth factor b family
(reviewed in Morohashi, 1999). In addition, SF-1 is important for
the regulation of the transcriptional repressor, dosage-sensitive sex
reversal-adrenal hypoplasia congenita critical region on the X
chromosome, gene 1 (DAX-1) (Burris et al, 1995; Kawabe et al,
1999), which was recently found to bind RNA and shuttle between
nucleus and cytoplasm (Lalli et al, 2000). Mutations in DAX-1 were
found to cause X-linked adrenal hypoplasia congenita (AHC) and
the associated hypogonadotropic hypogonadism (HHG)
(Muscatelli et al, 1994), demonstrating that DAX-1, like SF-1, is
also crucial for adrenal and gonadal development. DAX-1 shares a
similar tissue distribution with SF-1 and has been shown to interact
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directly with SF-1 to repress its transcriptional activity (Ito et al,
1997; Zazopoulos et al, 1997). DAX-1 is also able to block the
transcriptional activity of other proteins involved in steroidogenesis
and thus impede the steroidogenic process. One such regulated
gene includes StAR, a protein that mediates the ®rst step of
steroidogenesis by transporting extramitochondrial cholesterol into
the inner mitochondrial membrane for conversion into pregneno-
lone by CYP11A1 (Stocco and Sodeman, 1991; Zazopoulos et al,
1997; Reinhart et al, 1999).
In addition to steroidogenic tissues, Asa et al (1996) showed
preferential SF-1 expression in human anterior pituitary gonado-
tropes, and Ramayya et al (1997) reported the presence of SF-1
mRNA transcripts by northern blot analysis in the spleen and
widespread expression throughout many components of the human
brain and central nervous system. Similarly, DAX-1 has also been
detected by reverse transcriptase-polymerase chain reaction (RT-
PCR) in nonsteroidogenic tissues, including human adult and fetal
brain, pituitary, and hypothalamus, in addition to its prevalent
expression in steroidogenic tissues (Guo et al, 1995).
Human skin is a target tissue for the steroid hormones released
from and tightly controlled by the hypothalamic-pituitary-adrenal-
gonadal axis. The capacity for skin to intracellularly metabolize
weak circulating androgens such as dehydroepiandrostenedione
(DHEA) and androstenedione into the more potent forms,
testosterone and dihydrotestosterone (DHT), has been well
characterized and these hormones are known to be involved in
the regulation of human hair growth. In contrast, it has not yet
been proved that human skin is an organ that actively participates in
de novo steroid biosynthesis from cholesterol, even though most of
the essential components required for androgen and estrogen
synthesis, such as cholesterol and the steroidogenic enzymes,
namely CYP11A1, CYP17, CYP19, 3b-HSD, 17b-HSD, and 5a-
reductase, have been identi®ed in human skin (Courchay et al,
1996; Slominski et al, 1996; Venencie et al, 1999).
The identi®cation and localization of all the cytochrome P450
steroid hydroxylases in human skin prompted us to investigate
whether their expression in skin is controlled in a similar manner as
found in the adrenal cortex. In this study, we have shown for the
®rst time using immuno-detection, reverse transcription and
polymerase chain reaction (RT-PCR) techniques that DAX-1
and SF-1 appear to be expressed in human skin and its appendages.
Our ®ndings also show some differences in expression, in
particular, DAX-1 immunoreactivity is predominantly localized
to basal cells in the epidermis, whereas SF-1 immunoreactivity is
found in all layers except the stratum corneum.
MATERIALS AND METHODS
Cell culture and tissues Primary human skin keratinocytes were
cultured on an irradiated mouse 3T3 feeder layer as previously described
(Navsaria et al, 1994) in medium consisting of a mixture of Dulbecco's
modi®ed Eagle's medium and Ham's F12 in a ratio of 3:1 (vol/vol),
supplemented with 10% (vol/vol) fetal calf serum, 0.4 mg hydrocortisone
per ml, 10±10 M cholera toxin, 10 ng epidermal growth factor per ml,
and 5 mg insulin per ml. HaCaT cells, a spontaneously immortalized
keratinocyte cell line (Boukamp et al, 1988), were cultured using the
same medium as described above but in the absence of a 3T3 feeder
layer. The primary keratinocytes and HaCaT cells were cultured in a
humidi®ed atmosphere at 37°C with 10% CO2. Primary human
preadipocytes were cultured in medium consisting of a mixture of
Dulbecco's modi®ed Eagle's medium and Ham's F12 in a ratio of 1:1
(vol/vol), supplemented with 10% (vol/vol) fetal calf serum and 4%
(vol/vol) glutamine. aT3-1 cells, a mouse gonadotrope-derived cell line
(Windle et al, 1990), were maintained in a monolayer culture in high
glucose (4500 mg per ml) Dulbecco's modi®ed Eagle's medium with 10%
(vol/vol) fetal calf serum, 100 units penicillin per ml, 100 mg
streptomycin per ml, and 125 mg fungizone per ml (Life Technologies,
Paisley, U.K.). NCI-H259R human adrenocortical cells (Bird et al, 1993)
were cultured in a 1:1 (vol/vol) mixture of Dulbecco's modi®ed Eagle's
medium and Ham's F12 medium supplemented with 15 mM HEPES,
6.25 mg insulin per ml, 6.25 mg transferrin per ml, 6.25 ng selenium per
ml, 1.25 mg bovine serum albumin per ml, 5.35 mg linoleic acid per ml,
and 2% Ultroser G (Life Technologies, Paisley, U.K.). Pre-adipocytes,
aT3-1 cells, and H295R cells were grown at 37°C in a humidi®ed
atmosphere with 5% CO2.
Facelift skin was obtained from male patients undergoing surgery and
was immediately snap-frozen in liquid nitrogen and stored at ±80°C until
required for hair follicle isolation, sectioning, and protein and RNA
extraction. Approval by the East London and City Health Authority
Research Ethics Committee (number: T/98/008) for the use of redun-
dant human skin was given. Hair follicles were isolated from facelift skin
and transiently maintained in culture as previously described (Philpott
et al, 1990). Removal of dermal papilla cells from the isolated hair follicle
was carried out according to the method of Jahoda et al (1984). Brie¯y,
the follicle bulb was dissected away from the isolated hair follicles by
means of a scalpel. Using a sterile syringe needle the dermal papilla cells
were microdissected out and seeded into T25 tissue culture ¯asks
containing Williams E media (Sigma, Poole, U.K.), supplemented with
15% (vol/vol) fetal calf serum, 100 ng hydrocortisone per ml, 100 units
penicillin G per ml (Sigma), 100 mg streptomycin per ml, and 2 mM
glutamine. The cells were cultured in a humidi®ed atmosphere at 37°C
with 5% CO2 until they reached 70% con¯uence, after which they were
split one in ®ve. Passage two cells were harvested and used for
immunocytochemistry and protein extraction.
RNA isolation Total RNA was isolated from snap-frozen facelift skin
using TRIzol LS Reagent (Gibco BRL, Life Technologies) and from cell
cultures using the Qiagen RNeasy Mini kit (Qiagen, Crawley, U.K.).
Methods were followed according to the manufacturers' instructions.
RNA extracted using either method was treated with DNase I (Gibco
BRL, Life Technologies), followed by ethanol precipitation to obtain
concentrated RNA. After resuspension in RNase-free water the DNase I
was removed using the cleanup protocol from the RNeasy mini kit. The
concentration of RNA was estimated by measuring the absorbance at
260 nm and stored at ±70°C until required.
RT-PCR First-strand DNA synthesis was carried out using a First-
Strand cDNA Synthesis Kit (Amersham Pharmacia Biotech,
Buckinghamshire, U.K.). Brie¯y, 5 mg of total RNA in 20 ml of RNase-
free water was heated to 65°C for 10 min and chilled on ice, after which
it was added to 11 ml of Bulk First-Strand Reaction Mix, 1 ml of a 5 mg
per ml Not I-d(T)18 bifunctional primer solution and 1 ml of a 200 mM
dithiothreitol solution. The total reaction mix was incubated at 37°C for
1 h and stored at ±20°C until use. For PCR, 5 ml of First-strand cDNA
were directly pipetted into a mastermix composed of 5 ml of 10 3 PCR
buffer (Amersham Pharmacia Biotech), 2.5 units of Taq DNA
polymerase (Amersham Pharmacia Biotech), 20 mM nucleotide mix
(Amersham Pharmacia Biotech), and 40 pmol of primers made up to a
total volume of 50 ml using water. PCR of the SF-1 product also
required the addition of 5% (vol/vol) dimethyl sulfoxide to the
mastermix to remove any secondary structures present in the cDNA
caused by GC-rich regions. All primers used were gene-speci®c and
intron spanning and included SF-1 forward 5¢-CCTCATCCGGTG-
TGAGAGC-¢3 (nucleotide 987, GenBank accession: D84206), and SF-1
reverse 5¢-GGTGCACGTGTAGTGCTTGT-¢3 (nucleotide 371,
GenBank accession: D84207), which amplify a product of 198 bp,
DAX-1 forward 5¢-AAGGAGTACGCCTACCTCAA-¢3, and DAX-1
reverse 5¢-TCCATGCTGACTGTGCCGAT-¢3 (nucleotides 1359±1592,
GenBank accession: S74720), which amplify a product of 251 bp. Prior
to ampli®cation, the PCR reactions were heated for 3 min at 94°C to
remove any secondary structures present in the cDNA-RNA
heteroduplex. Ampli®cation was carried out for 35 cycles, with
denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension
at 72°C for 45 s in a Perkin-Elmer Thermocycler. PCR products were
separated by electrophoresis on a 1.6% agarose gel accompanied by a
fX174 DNA Hae III digest molecular weight marker (Promega, Hants,
U.K.) to determine the size of products, and visualized with ethidium
bromide. The PCR products were puri®ed using the QIAquick gel
extraction kit (Qiagen, Crawley, U.K.) and sequenced on both strands
using the ABI Prism BigDye terminator cycle sequencing ready reaction
kit (PE Applied Biosystems, Warrington, U.K.). The human
adrenocortical H295R cell line was used as a positive control for RT-
PCR as they have previously been shown to express DAX-1 by
immuno¯uorescence (Lalli et al, 2000) and SF-1 by northern analysis
(Leers-Sucheta et al, 1997). DNA sequencing of products ampli®ed from
skin and H295R cDNA con®rmed their identity with SF-1 and DAX-1
on the GenBank database.
Immunohistochemistry Six-micrometer thick longitudinal sections
were cut from hair-bearing human male scalp skin and mounted on
superfrost microscope slides. The slides were stored at ±80°C until
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needed for immunohistochemistry. The slides were left to air-dry at
room temperature for 20 min followed by treatment in 3% (vol/vol)
H2O2 in methanol for 15 min to block endogenous peroxidase activity.
The sections were preincubated with neat horse serum for 20 min and
then incubated with a rabbit polyclonal antibody raised against mouse
SF-1 (Upstate Biotechnology, Lake Placid, NY) at a concentration of
6.0 mg per ml, and a rabbit polyclonal antibody raised against human
DAX-1 (Santa Cruz Biotechnology, Santa Cruz, CA) at a concentration
of 0.5 mg per ml, for 1 h at room temperature in antibody diluent
(5 mM Tris, 140 mM NaCl, 6 mM NaN3, 16 mM HCl, 0.4 mg per ml
bovine serum albumin, and 5.6 mg per ml caesin, pH 7.6). Prior to use
of the primary antibodies a titration study was carried out to determine
the optimum concentration for their use on histological sections.
Secondary and tertiary complexes were formed using the Vectastain
Universal Elite ABC kit (Vector Laboratories, Burlingame, CA). Brie¯y,
specimens were washed in Tris-buffered saline (TBS) 20 mM Tris-base;
pH 7.6, 140 mM NaCl and incubated with an antihorse biotinylated IgG
in 6% blocking serum (Vector Laboratories) for 45 min at room
temperature. The sections were subsequently washed in TBS followed by
incubation with an avidin-biotin-peroxidase complex (Vector
Laboratories) for 45 min at room temperature. Immunoreactivity was
visualized using diaminobenzidine (DAB) (BioGenex, San Ramon, CA)
as a chromogenic substrate in H2O2. Sections were dehydrated and then
mounted in DePex mounting medium (BDH Laboratory Supplies,
Poole, U.K.). Omission of the primary antibody for negative controls
resulted in no detection demonstrating speci®city of the primary
antibodies (data not shown).
Immunocytochemistry Dermal papilla cells, HaCaT cells, normal
human keratinocytes, preadipocytes, and aT3-1 cells were trypsinized and
seeded at a density of 1 3 105 cells on to ¯ame-sterilized glass coverslips
that had been placed in 6-well tissue culture dishes. The cells were grown
in their respective medium (as described above) for 2d before
immunocytochemistry was carried out. After 48 h, culture media was
aspirated and the coverslips were washed three times with TBS. Cell
®xation and blocking of endogenous peroxidases was carried out by
incubating the coverslips with a 3% (vol/vol) H2O2 in methanol solution
for 15 min at room temperature. The cells were washed three times in
TBS and treated with TBS/0.1% (vol/vol) Triton X-100 for 15 min at
room temperature to permeabilize the cells. This was followed by three
washes in TBS, incubation for 20 min at room temperature in neat horse
serum to block nonspeci®c binding, and incubation for 1 h at room
temperature in either 0.5 mg per ml anti-DAX-1 antibody or 12.0 mg per
ml anti-SF-1 antibody in antibody diluent. After incubation in primary
antibody was completed, the cells were washed three times in TBS,
followed by secondary and tertiary complexing using the Vectastain
Universal Elite ABC kit and color development using DAB, as described
above. Control experiments included omission of the primary antibody
(negative control), which resulted in no detection, demonstrating
speci®city of the primary antibodies, and by using aT3-1 cells as a positive
control for DAX-1 and SF-1 immunoreactivity, which were previously
shown to express SF-1 by northern blotting (Barnhart and Mellon, 1994),
and DAX-1 by RNase protection assay (Ikeda et al, 1996).
Western blot analysis Protein was extracted from 5 3 106 cells of each
cell type grown in T25 ¯asks using a modi®ed method of Schreiber et al
(1989). Brie¯y, culture medium was removed and the cells were washed
in ice-cold phosphate-buffered saline (PBS). The cells were then harvested
by scraping in cold PBS and pelleted by centrifugation at 1300 3 g, 4°C,
for 5 min. The supernatant was discarded and the cells were resuspended
in 400 ml of cold buffer A (10 mM HEPES pH 7.9; 10 mM KCl,
0.1 mM EDTA; 0.1 mM EGTA, 1 mM dithiothreitol, and 0.5 mM
PMSF). The cells were left on ice for 15 min, followed by the addition of
25 ml of a 10% Nonidet (NP-40) solution made in buffer A. The cells
were immediately vortexed for a duration of 10 s and then centrifuged at
16000 3 g for 30 s. The supernatant was removed prior to the
resuspension of the pellet in 50 ml of buffer B (20 mM HEPES pH 7.9;
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA; 1 mM dithiothreitol; 1 mM
phenylmethylsulfonyl ¯uoride) and then the cells were thoroughly mixed
on ice for 15 min using a shaking platform. The nuclear extract was
centrifuged for 5 min, 16000 3 g, at 4°C and the supernatant containing
the nuclear protein was collected and stored at ±70°C. Nuclear protein
concentration was determined using the Bradford assay (Bio-Rad, Hemel
Hempstead, U.K.) with bovine serum albumin as standard. Fifteen
micrograms of each nuclear protein extract was mixed with a 2:1 volume
of sample buffer [125 mM Tris (hydroxymethyl) aminomethane pH 6.8,
5% (vol/vol) b-mercaptoethanol, 20% (vol/vol) glycerol, 4% sodium
dodecyl sulfate, and 0.02% bromophenol blue] and separated by SDS-
polyacrylamide gel electrophoresis, using precast 10% Tris-HCl
polyacrylamide gels (Bio-Rad, Hemel Hempstead, U.K.) for 1 h at 90 V;
thereafter, proteins were electrotransferred to a nitrocellulose membrane
for 1 h at 90 V. The membrane was blocked using 5% (vol/vol) non-fat
dry milk in TBS/0.1% (vol/vol) Tween-20, pH 7.5, for 1.5 h at 20°C,
prior to overnight incubation in 0.08 mg per ml anti-DAX-1 in blocking
buffer, at 4°C. The nitrocellulose membrane was washed three times with
TBS/0.1% (vol/vol) Tween-20 for 5 min each, and subsequently
incubated with goat anti-rabbit horseradish peroxidase (DAKO,
Cambridge, U.K.) at 0.03 mg per ml in blocking buffer for 1.5 h at room
temperature. Following three washes in TBS/0.1% (vol/vol) Tween-20,
the protein bands were visualized using an enhanced chemiluminescence
ECL detection system (Amersham Pharmacia Biotech).
RESULTS
Immunolocalization of DAX-1 and SF-1 in human
skin Immunohistochemistry on human facelift skin sections for
DAX-1 and SF-1 revealed distinctive differential nuclear staining
for both transcription factors in speci®c regions of the human hair
follicle and skin (Fig 1). Within the epidermis, prominent nuclear
and cytoplasmic DAX-1 expression was detected in the basal layer,
with decreasing expression towards the differentiated suprabasal
keratinocytes (Fig 1a), whereas nuclear SF-1 immunoreactivity
was diffuse across all strata of the epidermis, namely the stratum
basale, stratum spinosum, and stratum granulosum (Fig 1b).
Immunolocalization for both transcription factors was also
apparent in the dermal ®broblasts (Fig 1a, b). In the human hair
follicle, there was a distinguishable difference in DAX-1 and SF-1
staining (Fig 1c, d). Strong nuclear staining for DAX-1 was
con®ned to the outer root sheath with weaker expression in the
inner root sheath, matrix cells (Fig 1c) and signi®cantly lower
immunoreactivity in the dermal papilla cells (Fig 1c, e). There was
no difference in distribution for SF-1 throughout the hair follicle in
comparison with DAX-1 expression, but the levels of
immunoreactivity for SF-1 in the outer root sheath, inner root
sheath, matrix cells (Fig 1d), and dermal papilla cells of the hair
bulb (Fig 1d, f) were stronger than that for DAX-1. A similar
pattern of expression for both orphan nuclear receptors was
detected in the exocrine glands of skin, including the basal layer and
sebocytes of the sebaceous gland (Fig 1g, h) and in the sweat glands
(Fig 1i, j). Omission of the primary antibody as a negative control
for immunohistochemistry resulted in no staining (data not shown).
Immunolocalization studies have also been carried out on facelift
skin from female subjects (data not shown) but no apparent
differences were observed in the expression pattern for SF-1 and
DAX-1 between male and female skin.
Immunocytochemistry con®rms co-localization of DAX-1
and SF-1 in cells derived from human skin Co-localization
of DAX-1 with SF-1 in the cells of human skin was examined by
immunocytochemistry as SF-1 has previously been reported to
regulate DAX-1 gene transcription (Burris et al, 1995; Kawabe et al,
1999). Nuclear staining for DAX-1 and SF-1 was observed in every
cell type studied, including primary cultures of epidermal
keratinocytes (Fig 2a, b), the immortalized keratinocyte cell line
HaCaT (Fig 2d, e), primary cultures of preadipocytes (Fig 2g, h),
primary cultures of dermal papilla cells (Fig 2j, k), and in the
positive control murine aT3-1 gonadotrope cells (Fig 2m, n). The
presence and co-localization of DAX-1 in the dermal papilla cells
with SF-1 was con®rmed by immunocytochemistry; however, a
longer incubation in the substrate was required for visual detection
of DAX-1, con®rming earlier immunohistochemical observations
in whole human skin that less DAX-1 immunoreactivity appeared
to be present in the dermal papilla cells in comparison with SF-1.
Immunocytochemical analysis on primary dermal ®broblasts also
resulted in nuclear staining for both transcription factors (data not
shown), suggesting that nuclear staining observed earlier in the
dermis of whole human skin is due to ®broblasts expressing DAX-1
and SF-1. Speci®c staining was not observed in any of the negative
controls for each cell type in which the primary antibodies were
omitted (Fig 2c, f, i, l, o).
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DAX-1 and SF-1 mRNA transcripts are expressed in human
skin RT-PCR analysis revealed the presence of DAX-1 and SF-
1 mRNA in whole human skin (Fig 3). The gene-speci®c and
intron spanning primers for SF-1 were designed to ¯ank the coding
sequence of the DNA-binding domain of SF-1 to produce a 198 bp
amplicon. Ampli®cation of the expected 198 bp product from
Figure 1. Immunohistochemical analysis reveals nuclear staining for both DAX-1 and SF-1 in speci®c regions of the human hair follicle
and skin. Snap-frozen human facelift skin was processed for immunohistochemistry using anti-DAX-1 antibody and anti-SF-1 antibody with a DAB
detection system. DAX-1 and SF-1 are detected in the epidermis and the dermis of human skin (a) and (b), respectively. There is differential DAX-1
and SF-1 immunoreactivity in the human hair follicle (c) and (d), respectively, and in the hair bulb shown at a higher magni®cation (e) and ( f ). DAX-1
and SF-1 are localized in the sebaceous gland (g) and (h), respectively, and in the sweat glands (i) and (j). Abbreviations: BL, basal layer; DER, dermis;
DP, dermal papilla; E, epidermis; HS, hair shaft; IRS, inner root sheath; MC, matrix cells; ORS, outer root sheath; SG, sebaceous gland; SW, sweat
gland. Scale bars: (a, b, g, h) 64 mm; (c, d) 100 mm; (e, f ) 34 mm; (i, j) 72 mm.
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whole human skin and from the positive control H295R
adrenocortical cell line only occurred in the presence of 5%
dimethylsulfoxide in the PCR mastermix (Fig 3), but the expected
product was also accompanied by a smaller band of 161 bp in size
(data not shown). Further investigations of the 161 bp product
revealed that the SF-1 primers were mispriming and annealing to
genomic DNA contaminants present in the PCR reaction to
produce a smaller 161 bp amplicon, which contained most of
intron 2 and part of exon 3 of the SF-1 gene. DNase I treatment of
the RNA extracted from human skin and adrenocortical cells
eliminated the appearance of the 161 bp product with the expected
198 bp product being ampli®ed alone. RT-PCR of whole human
skin and H295R cell RNA yielded the expected 251 bp DAX-1
product (Fig 3). DNA sequencing of the 198 bp SF-1 band and
the 251 bp DAX-1 band ampli®ed from whole human skin and the
H295R cell line by their respective primers, con®rmed their
identity with human DAX-1 and SF-1 sequences in the human
GenBank database.
Western analysis con®rms the expression of DAX-1 protein
in human skin cells Using the same DAX-1 antibody as that
Figure 3. DAX-1 and SF-1 mRNA is detected in whole human
skin by RT-PCR. Lane 1, the 198 bp SF-1 mRNA amplicon was
detected in whole human skin; lane 2, and in the positive control human
adrenocortical H295R cells. Lane 3, the 251 bp DAX-1 mRNA
amplicon was detected in whole human skin; lane 4, and in the positive
control human adrenocortical H295R cells. Lanes 5 and 6, SF-1 and
DAX-1 negative controls without cDNA, respectively; lane 7, fX174
DNA Hae III digest molecular weight markers.
Figure 2. Nuclear localization of DAX-1 and
SF-1 by immunocytochemistry in cultured
cells derived from human skin. Methanol ®xed
cells cultured on glass coverslips were
permeabilized with 0.1% (v/v) Triton X-100 and
incubated in primary antibodies against DAX-1
and SF-1. Nuclear immunoreactivity for DAX-1
and SF-1 is apparent in primary cultures of human
keratinocytes (a) and (b), respectively;
immortalized human keratinocytes (d) and (e);
primary cultures of human preadipocytes (g) and
(h) and primary cultures of human dermal papilla
cells (j) and (k). DAX-1 and SF-1 were detected
in the positive control cells, the aT3-1 cells (m)
and (n), respectively. The negative controls for
each cell type in which the primary antibodies
were omitted (c, f, i, l, o) do not show any nuclear
staining. Scale bars: (a±f ) 25 mm; (g±l) 50 mm;
(m±o) 12.5 mm.
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used for immunocytochemistry, a correct sized band corresponding
to human DAX-1 protein was observed by Western blotting
con®rming the expression of DAX-1 in primary cultures of dermal
papilla cells, HaCaT cells, primary cultures of normal human
keratinocytes, primary cultures of preadipocytes, and in the positive
control aT3-1 gonadotrope cell line (Fig 4). Quantitation and
normalization of nuclear protein in each cell extract was performed
prior to loading and Coomassie blue staining (data not shown)
con®rmed equal protein loading to each lane. Despite
demonstrating the presence of SF-1 protein in skin by
immunohistochemistry we have as yet been unable to show SF-1
protein by immunoblotting. This may be because the commercially
available SF-1 antibody lacks the required sensitivity for use in this
technique.
DISCUSSION
Since the initial studies when SF-1 was identi®ed and named,
several human tissues other than steroidogenic tissues have also
been shown to express this orphan nuclear receptor. Our studies
using immunohistochemistry, mRNA expression, and western
blotting would suggest that these orphan nuclear receptors are also
present in human skin. Immunohistochemistry of DAX-1 and SF-1
revealed a nuclear staining pattern in human skin, which is in
agreement with their localization in steroidogenic tissues such as
the adrenal cortex. Although we found predominant nuclear DAX-
1 staining in skin, cytoplasmic staining was also observed in the
basal layer of the epidermis, a ®nding which is in agreement with
that recently made by Lalli et al (2000), who reported that DAX-1
is able to shuttle between the nucleus and cytoplasm. Western
analysis con®rmed that the nuclear protein detected by immuno-
histochemistry and immunocytochemistry was indeed DAX-1.
The expression of SF-1 and DAX-1 mRNA transcripts was
con®rmed in whole human skin; however, we experienced
dif®culties in amplifying the SF-1 transcript from skin by PCR
and found that this was only feasible from skin that was immediately
snap-frozen upon removal.
Our immunoctyochemical studies show that both transcription
factors co-localize with each other in all skin-derived cultured cells,
including human keratinocytes, dermal papilla cells, and preadipo-
cytes. A distinct staining pattern was also observed for DAX-1 in
the epidermis of human skin with prominent staining in the basal
layer compared with the scattered pattern for SF-1 in all layers,
except the corni®ed layer. By immunohistochemistry DAX-1
immunoreactivity also appeared to be lower than that found for SF-
1 in dermal papilla cells; however, factors such as the af®nity of the
antibodies against their antigens and the concentrations of the
antibodies used must be taken into consideration.
The expression of the steroidogenic enzymes CYP11A1,
CYP17, and CYP21 in the adrenal cortex and CYP19 in the
gonads is under the transcriptional control of DAX-1 and SF-1 and
many of these enzymes have previously been reported to be
expressed throughout human skin (Table I).
The distribution of all the steroidogenic enzymes in different
regions of human skin is concordant with our immunohisto-
chemical ®ndings for DAX-1 and SF-1 expression, suggesting that
both transcription factors may also be involved in regulating their
gene expression in human skin. Furthermore, the cutaneous
expression of DAX-1 and SF-1 supports the hypothesis that
de novo steroid synthesis from cholesterol could take place in human
skin.
It was recently shown that oxysterols such as 25-hydroxy-
cholesterol are able to induce human keratinocyte differentiation by
increasing activator protein 1 (AP-1)-dependent transcription of
the involucrin gene, which encodes a protein involved in the
formation of the corni®ed envelope of differentiated keratinocytes
(Hanley et al, 2000). 25-hydroxycholesterol has also been shown to
stimulate SF-1-dependent transcription in non-steroidogenic CV-1
cells and was believed to be a ligand for the orphan receptor (Lala et
al, 1997). Mellon and Bair (1998) demonstrated that SF-1
transcriptional activity remained unaffected in the presence of
oxysterols in steroidogenic mouse MA-10 Leydig cells and showed
that oxysterols were not ligands for SF-1 in known steroidogenic
cells. It is conceivable, however, that oxysterols may act as ligands
Table I. Location of the steroidogenic enzymes in human skin, the expression of which are under the transcriptional
control of SF-1 and DAX-1 in the adrenal cortex and gonads
Enzyme Function in adrenal/gonads Location in human skin Reference
CYP11A1 (cholesterol
side-chain cleavage
enzyme or desmolase)
20a-hydroxylation, 22-hydroxylation and scission of the
cholesterol side-chain to yield pregnenolone
Basal layer of epidermis and
eccrine gland
Venencie et al, 1999
CYP17
(17 a-hydroxylase)
17 a-hydroxylation of pregnenolone and progesterone to 17-
hydroxypregnenolone and 17-hydroxyprogesterone, respectively,
followed by scission of the C17, 20 carbon bond to yield
dehydroepiandrosterone and androstenedione, respectively
Epidermis, inner root sheath,
outer root sheath, sebaceous
gland, and sweat gland
Venencie et al, 1999
CYP21 (21-hydroxylase) 21-hydroxylates progesterone and 17-hydroxyprogesterone to
yield deoxycorticosterone and 11-deoxycortisol, respectively
Whole skin Slominski et al, 1996
CYP19 (aromatase) Catalyses aromatization of C19 antibodies to form estrogens Adipocytes
Fibroblasts
Stratum granulosum and
sebocytes
Dermal papilla cells, ®broblasts,
and outer root sheath
keratinocytes
Cleland et al, 1983
Berkovitz et al, 1984
Venencie et al, 1999
Lachgar et al, 1999
Figure 4. DAX-1 protein is detected in skin derived cells by
Western blotting. Nuclear protein extracts from skin derived cells
blotted onto a nitrocellulose membrane were analyzed for the presence
of DAX-1 protein using 0.08 mg per ml anti-DAX-1 antibody. Lane 1,
primary culture of normal human keratinocytes (NHK); lane 2, HaCaT
cells; lane 3, primary culture of preadipocytes (P-A); lane 4, primary
culture of dermal papilla cells (DP); lane 5, positive control aT3-1
gonadotrope cells.
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for SF-1 in human keratinocytes. Moreover, SF-1 is a likely
candidate through which oxysterols may induce keratinocyte
differentiation as the activation function 2 (AF2) subdomain that
resides in the ligand binding domain of SF-1 is able to interact with
AP-1 to modulate gene transcription (Li et al, 1998). Our
immunohistochemical data of DAX-1 and SF-1 localization in
the human epidermis suggests that SF-1 may facilitate cellular
mechanisms in skin such as keratinocyte differentiation in a positive
manner, whilst DAX-1 could act in a repressive manner. The
persistent expression of DAX-1 and SF-1 in suprabasal cells,
however, might imply additional functions for these transcription
regulators.
The well-described function of these transcription factors during
development and their widespread expression in most components
of human skin and the pilosebaceous unit, provokes speculation
that they may be involved in some regulatory aspects of the human
hair cycle by controlling cutaneous steroidogenesis. Furthermore, if
DAX-1 and SF-1 are indeed regulating local steroidogenesis in
human skin, they may in¯uence further effects in the steroidogenic
cascade by controlling the availability of steroids for their
conversion into more potent forms such as DHT, and thus be
involved in inciting pathologies associated with potent androgens,
for instance acne or hirsutism. Further studies must be performed to
clarify the functional signi®cance of DAX-1 and SF-1, and to
elucidate the intriguing roles that they may play in human skin.
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